Paul Josephs Biography and Net Worth

President & CEO of Lifecore Biomedical

Paul Josephs brings more than 30 years of pharmaceutical industry experience to Lifecore, including more than 25 years of CDMO experience. From 2021 until April 2024, Mr. Josephs served as President & Chief Executive Officer and a member of the Board of Directors at Woodstock Sterile Solutions, a specialized, full-service CDMO. Prior to joining Woodstock, Mr. Josephs served as Head of CDMO – Global Business Development at Viatris (formerly known as Mylan) since 2016 when it acquired DPT Laboratories. Mr. Josephs’ work with DPT Laboratories began in 1997, where he held numerous progressive roles in sales and business development, culminating with a position of Senior Vice President, Sales, Marketing & Corporate Development. He holds a Bachelor of Arts degree from the University of Western Ontario in Canada.

What is Paul Josephs' net worth?: The estimated net worth of Paul Josephs is at least $4.30 million as of January 8th, 2025. Mr. Josephs owns 559,717 shares of Lifecore Biomedical stock worth more than $4,298,627 as of December 4th. This net worth evaluation does not reflect any other investments that Mr. Josephs may own. Learn More about Paul Josephs' net worth.
How do I contact Paul Josephs?: The corporate mailing address for Mr. Josephs and other Lifecore Biomedical executives is 2811 AIRPARK DRIVE, SANTA MARIA CA, 93455. Lifecore Biomedical can also be reached via phone at (800) 454-1355 and via email at [email protected]. Learn More on Paul Josephs' contact information.
Has Paul Josephs been buying or selling shares of Lifecore Biomedical?: Paul Josephs has not been actively trading shares of Lifecore Biomedical during the last quarter. Most recently, on Wednesday, January 8th, Paul Josephs bought 17,000 shares of Lifecore Biomedical stock. The stock was acquired at an average cost of $5.74 per share, with a total value of $97,580.00. Following the completion of the transaction, the chief executive officer now directly owns 559,717 shares of the company's stock, valued at $3,212,775.58. Learn More on Paul Josephs' trading history.
Are insiders buying or selling shares of Lifecore Biomedical?: During the last year, Lifecore Biomedical insiders bought shares 1 times. They purchased a total of 17,000 shares worth more than $97,580.00. During the last year, insiders at the sold shares 8 times. They sold a total of 1,485,182 shares worth more than $9,824,030.88. The most recent insider tranaction occured on May, 28th when Major Shareholder Aron R English sold 150,419 shares worth more than $1,070,983.28. Insiders at Lifecore Biomedical own 32.0% of the company. Learn More about insider trades at Lifecore Biomedical.
Information on this page was last updated on 5/28/2025.

Paul Josephs Insider Trading History at Lifecore Biomedical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/8/2025	Buy	17,000	$5.74	$97,580.00	559,717

Paul Josephs Buying and Selling Activity at Lifecore Biomedical

Lifecore Biomedical Company Overview

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Today's Range

Now: $7.77

$7.50

$7.78

50 Day Range

MA: $7.18

$6.49

$8.22

2 Week Range

Now: $7.77

$4.76

$8.85

Volume

115,368 shs

Average Volume

161,038 shs

Market Capitalization

$291.14 million

P/E Ratio

N/A

Dividend Yield